Telomere length versus hormonal and bone mineral status in healthy elderly men

被引:61
作者
Bekaert, S [1 ]
Van Pottelbergh, I
De Meyer, T
Zmierczak, H
Kaufman, JM
Van Oostveldt, P
Goemaere, S
机构
[1] Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, Ghent, Belgium
[2] Ghent Univ Hosp, Dept Internal Med, Unit Osteoporosis & Metab Bone Dis, B-9000 Ghent, Belgium
关键词
telomere length; biomarker; ageing; bone loss; senile osteoporosis;
D O I
10.1016/j.mad.2005.04.007
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Telomeres, the termini of linear chromosomes, exert a key role in the process of cellular ageing. Progressive telomere shortening is implicated in senescence in vitro and ample evidence exists to support the hypothesis that telomere length is correlated with chronological age and ageing phenotypes in vivo. In this study, we assessed whether mean telomere length of peripheral blood leukocytes predicts age-associated bone loss and/or is related to sex steroid status in an elderly healthy male population (71-86 years). Out of this population, we selected 110 samples for telomere restriction fragment (TRF) length analysis. Fasting blood was analysed for testosterone, estradiol, sex hormone binding globulin and biochemical markers of bone turnover. Also, the bioavailable fractions of sex steroids were calculated. Bone mineral density was measured at baseline and longitudinal follow-up was available for 84 men. We found that mean TRF length was inversely correlated with age (r = -0.19; P = 0.049). Although no corelations were found with sex steroids or BMD at baseline, age corrected mean TRF length was associated with longitudinal bone loss for different distal forearm sites (P < 0.05). Further studies are required to confirm our results, yet in this study, the predictive value of telomere length for bone loss appears to be substantial, hence underscoring the role of telomere length as a biomarker of ageing phenotypes. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1115 / 1122
页数:8
相关论文
共 53 条
  • [1] TELOMERE LENGTH PREDICTS REPLICATIVE CAPACITY OF HUMAN FIBROBLASTS
    ALLSOPP, RC
    VAZIRI, H
    PATTERSON, C
    GOLDSTEIN, S
    YOUNGLAI, EV
    FUTCHER, AB
    GREIDER, CW
    HARLEY, CB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) : 10114 - 10118
  • [2] Osteoimmunology - Bone versus immune system
    Arron, JR
    Choi, Y
    [J]. NATURE, 2000, 408 (6812) : 535 - 536
  • [3] Telomeres and essential hypertension
    Aviv, A
    Aviv, H
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 427 - 432
  • [4] Growth, telomere dynamics and successful and unsuccessful human aging
    Aviv, A
    Levy, D
    Mangel, M
    [J]. MECHANISMS OF AGEING AND DEVELOPMENT, 2003, 124 (07) : 829 - 837
  • [5] Fetal programming of coronary heart disease
    Barker, DJP
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (09) : 364 - 368
  • [6] Telomere biology in mammalian germ cells and during development
    Bekaert, S
    Derradji, H
    Baatout, S
    [J]. DEVELOPMENTAL BIOLOGY, 2004, 274 (01) : 15 - 30
  • [7] Telomere length as an indicator of biological aging - The gender effect and relation with pulse pressure and pulse wave velocity
    Benetos, A
    Okuda, K
    Lajemi, M
    Kimura, M
    Thomas, F
    Skurnick, J
    Labat, C
    Bean, K
    Aviv, A
    [J]. HYPERTENSION, 2001, 37 (02) : 381 - 385
  • [8] Telomere states and cell fates
    Blackburn, EH
    [J]. NATURE, 2000, 408 (6808) : 53 - 56
  • [9] Association between telomere length in blood and mortality in people aged 60 years or older
    Cawthon, RM
    Smith, KR
    O'Brien, E
    Sivatchenko, A
    Kerber, RA
    [J]. LANCET, 2003, 361 (9355) : 393 - 395
  • [10] Ferrini RL, 1998, AM J EPIDEMIOL, V147, P750